Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

33.69 USD +0.20 (+0.60%)
Official Closing Price Updated: 7:59 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
As Additional COVID Variants Surface, Questions Arise to Effectiveness of Vaccines to Combat New Strains
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
As Additional COVID Variants Surface, Questions Arise to Effectiveness of Vaccines to Combat New Strains
Financialnewsmedia.com News Commentary 
From PR Newswire
European Medicines Agency Accepts Pfizer’s Marketing Authorization Application for Its Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age or Older
Pfizer Inc. (NYSE:PFE) today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for its 20-valent pneumococcal conjugate vaccine... 
From Business Wire News Releases
EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing Authorization Application (MAA) for... 
From Business Wire News Releases
Thinking about trading options or stock in Moderna, Tesla, Pfizer, L Brands, or Wayfair?
InvestorsObserver issues critical PriceWatch Alerts for MRNA, TSLA, PFE, LB, and W. 
From PR Newswire
ViiV Healthcare Builds on Accelerate Initiative, Extending Community-Centered Approach Nationally to Disrupt Disparities in Care for Black Same-Gender-Loving Men Living With HIV
Tags Research, Reports & Publications Grants baltimore
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today they have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2)... 
From Business Wire News Releases
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
From GlobeNewswire News Releases
ViiV Healthcare Submits Supplemental New Drug Application to US FDA for Expanded Use of Cabenuva (cabotegravir, rilpivirine) as an HIV Treatment for Use Every 2-Months
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, announced today the submission of a supplemental... 
From Business Wire News Releases
Seven Bridges Selected by Pfizer to Support Data Management Solution for Single-Cell RNA Sequencing Data
Project Underscores Growing Importance of Efficient Genomic Data Management, Visibility and Retrieval 
From PR Newswire
U.S. FDA Accepts for Priority Review Pfizer’s Application for TicoVac™ (Tick-borne Encephalitis Vaccine)
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review the company’s Biologics License Application (BLA) for TicoVac™, its tick-borne... 
From Business Wire News Releases
Thinking about trading options or stock in Wynn Resorts, Pfizer, American Airlines, Carnival Corp, or Marriott International?
InvestorsObserver issues critical PriceWatch Alerts for WYNN, PFE, AAL, CCL, and MAR. 
From PR Newswire
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Angela Hwang, Group President, Pfizer Biopharmaceuticals Group, at the Cowen 41st Annual... 
From Business Wire News Releases
Thinking about trading options or stock in Moderna, Tesla, Pfizer, Plug Power, or Nio?
InvestorsObserver issues critical PriceWatch Alerts for MRNA, TSLA, PFE, PLUG, and NIO. 
From PR Newswire
Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA
From GlobeNewswire News Releases
Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
From GlobeNewswire News Releases
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant
From GlobeNewswire News Releases
Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
From GlobeNewswire News Releases
Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder
From GlobeNewswire News Releases
Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma
Pfizer Inc. (NYSE:PFE) today announced that the first participant has been dosed in the registration-enabling Phase 2 MagnetisMM-3 study (NCT04649359) of elranatamab (PF-06863135), an investigational... 
From Business Wire News Releases
Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY®, the companies’ COVID-19... 
From Business Wire News Releases
Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
From GlobeNewswire News Releases
U.S. FDA Approves PANZYGA® for the Treatment of Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for PANZYGA® (Immune Globulin Intravenous... 
From Business Wire News Releases
Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
From GlobeNewswire News Releases
Nextech AR’s Virtual Event Platform Selected by Canadian Surgery Forum for Its 2021 Virtual Trade Show
From GlobeNewswire News Releases
ViiV Healthcare receives Marketing Authorisation for Rukobia (fostemsavir), a first-in-class attachment inhibitor in combination with other antiretrovirals for the treatment of adults with multidrug-r
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, announced the European Marketing Authorisation... 
From Business Wire News Releases
Thinking about trading options or stock in Novavax, Pfizer, Activision Blizzard, Sony Corp, or General Electric?
InvestorsObserver issues critical PriceWatch Alerts for NVAX, PFE, ATVI, SNE, and GE. 
From PR Newswire
Pfizer Confirms U.S. Patent Term Extension for IBRANCE® (palbociclib) Until March 2027
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Patent and Trademark Office (USPTO) recently issued a U.S. Patent Term Extension (PTE) certificate for IBRANCE® (palbociclib). The certificate... 
From Business Wire News Releases
Thinking about trading options or stock in Pfizer, Daqo New Energy, Horizon Therapeutics, Intel Corp, or G1 Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for PFE, DQ, HZNP, INTC, and GTHX. 
From PR Newswire
PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 RESULTS AND RELEASES 5-YEAR PIPELINE METRICS
Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter 2020 and full-year 2020, raised 2021 guidance(4) for Adjusted diluted EPS(2) and provided 2021 financial guidance(4) for other... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.